These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11448346)

  • 1. Nasopharyngeal cancer: current status of management: a New York Head and Neck Society lecture.
    Wei WI
    Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):766-9. PubMed ID: 11448346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of nasopharyngeal carcinoma.
    Kraiphibul P; Atichartakarn V
    J Med Assoc Thai; 1992 Aug; 75(8):435-44. PubMed ID: 1300360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer of the nasopharynx.
    Maragos NE; DeSanto LW; Devine KD; Elveback LR
    Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol; 1977; 84(5):ORL915. PubMed ID: 919161
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical and histological characteristics of nasopharyngeal cancer in Sokoto, north-western, Nigeria.
    Iseh KR; Abdullahi A; Malami SA
    West Afr J Med; 2009 May; 28(3):151-5. PubMed ID: 20306729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nasopharyngeal cancer in childhood].
    Goumas P; Deftos C; Economidis J; Sissis T; Antonakopoulos C
    HNO; 1988 Apr; 36(4):147-9. PubMed ID: 3410750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasopharyngeal carcinoma: results of treatment by radiotherapy vs chemotherapy plus radiotherapy.
    Kraiphibul P; Atichartakarn V; Clongsusuek P; Kulapaditharom B; Ratanatharathorn V; Isarangkul W
    J Med Assoc Thai; 1991 Sep; 74(9):391-6. PubMed ID: 1791393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of nasopharynx cancer treatment: some prognostic factors].
    Zietek E; Jarema A; Wasilewska M; Matyja G; Boehlke M; Stańczyk D
    Otolaryngol Pol; 1999; 53(1):5-11. PubMed ID: 10337150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy in the management of squamous-cell carcinoma of the head and neck.
    Lamont EB; Vokes EE
    Lancet Oncol; 2001 May; 2(5):261-9. PubMed ID: 11905780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squamous cell carcinoma of the head and neck: past progress and future promise.
    Goepfert H
    CA Cancer J Clin; 1998; 48(4):195-8. PubMed ID: 9676533
    [No Abstract]   [Full Text] [Related]  

  • 10. Nasopharyngeal carcinoma: evidence for improved survival with combined chemoradiation.
    Smith TL; DiRugguero DC; Weissler MC
    Ear Nose Throat J; 1998 Jun; 77(6):484-9. PubMed ID: 9674323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival study and treatment strategy for second primary malignancies in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma.
    Tsou YA; Hua CH; Tseng HC; Lin MH; Tsai MH
    Acta Otolaryngol; 2007 Jun; 127(6):651-7. PubMed ID: 17503236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Aurora-B and FOXM1 predict poor survival in patients with nasopharyngeal carcinoma.
    Huang PY; Li Y; Luo DH; Hou X; Zeng TT; Li MQ; Mai HQ; Zhang L
    Strahlenther Onkol; 2015 Aug; 191(8):649-55. PubMed ID: 25986250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic factors in nasopharyngeal carcinoma in childhood and adolescence].
    Cao KJ; Li Y; Xie GF; Hong MH
    Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):134-7. PubMed ID: 16750020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term survival following chemotherapy for recurrent head and neck cancer: patient characteristics].
    Airoldi M; Bumma C; Cortesina G; Giordano C; Bussi M; Orecchia R; Succo G; Gabriele P; Bertetto O
    Acta Otorhinolaryngol Ital; 1994; 14(6):603-9. PubMed ID: 7740960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locally advanced nasopharyngeal cancer.
    Ensley JF; Youssef E; Kim H; Yoo G
    Curr Treat Options Oncol; 2001 Feb; 2(1):15-23. PubMed ID: 12057137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined treatment in carcinoma of the nasopharynx.
    Souhami L; Rabinowits M
    Laryngoscope; 1988 Aug; 98(8 Pt 1):881-3. PubMed ID: 3135458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current problems in radiotherapy, chemotherapy and staging of nasopharyngeal carcinoma (NPC).
    Tsao SY; Chua ET
    Ann Acad Med Singap; 1991 Sep; 20(5):649-55. PubMed ID: 1781651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Head and neck cancer in Saudi Arabia: retrospective analysis of 65 patients.
    al-Idrissi HY
    J Int Med Res; 1990; 18(6):515-9. PubMed ID: 2292333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Weekly paclitaxel with concurrent intensity-modulated radiotherapy for nasopharyngeal carcinoma: outcomes of a tolerance trial].
    Chen CY; Lu TX; Zhao C; Lu LX; Han F; Sun Y
    Ai Zheng; 2007 Apr; 26(4):398-402. PubMed ID: 17430660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 10-year survival of nasopharyngeal carcinoma. A report of 1,302 cases.
    Zhang EP; Liang PG; Li ZQ; Cai GL; Chen YF; Cai MD; Zeng XF; Guan XX
    Chin Med J (Engl); 1987 May; 100(5):419-24. PubMed ID: 3115715
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.